Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04251806
Other study ID # HUM00165595
Secondary ID R01HL147261
Status Active, not recruiting
Phase
First received
Last updated
Start date July 21, 2020
Est. completion date July 2026

Study information

Verified date April 2024
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to determine whether the risk for sleep-disordered breathing in infants with myelomeningocele (a severe form of spina bifida) differs among those who underwent fetal vs. postnatal surgery, and to examine the link between sleep-disordered breathing and neurodevelopment.


Description:

Myelomeningocele (MMC), the most severe form of spina bifida, is characterized by exposure of the spinal cord through a spinal defect. Sleep-disordered breathing (SDB) is common in children with MMC and is a risk factor for sudden death. Abnormal sleep physiology is likely multifactorial, related to MMC level, brainstem dysfunction, musculoskeletal factors, and pulmonary abnormalities. In infants, SDB may be treatable with oxygen, caffeine, or positive airway pressure. Yet, SDB screening is not routine, even in centers with specialized MMC programs. Evaluation of sleep in neonates who require intensive care is an emerging opportunity with potential for major impact on health and quality of life for affected children. As SDB and abnormal sleep are potentially treatable, early assessment and intervention could become an integral part of a multidisciplinary treatment strategy to optimize long-term medical and neurodevelopmental outcomes.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 173
Est. completion date July 2026
Est. primary completion date April 25, 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Years
Eligibility Inclusion Criteria: neonates with myelomeningocele who are cared for at a study center NICU are eligible to participate after myelomeningocele repair. Exclusion Criteria: - born at <30 weeks gestation - congenital anomalies that would predispose to sleep-disordered breathing (e.g. micrognathia) - confirmed or suspected genetic syndromes that alter developmental outcomes

Study Design


Intervention

Diagnostic Test:
neonatal polysomnography
This procedure will allow the detection of sleep-disordered breathing in the neonatal period.
2-year Bayley Exam
This procedure will evaluate neurodevelopmental outcomes.
2-year polysomnography
This procedure will allow the detection of sleep-disordered breathing at 2 years of age.

Locations

Country Name City State
United States Mott Children's Hospital Ann Arbor Michigan
United States Children's Hospital Colorado Aurora Colorado
United States University of Alabama at Birmingham Birmingham Alabama
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio
United States University of Texas-Houston Houston Texas
United States Children's Minnesota Minneapolis Minnesota
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Mayo Clinic Rochester Minnesota
United States Washington University Saint Louis Missouri

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of neonatal sleep-disordered breathing (SDB) in infants who had fetal versus postnatal myelomeningocele repair. Neonatal sleep studies will be used to capture neonatal Apnea-Hypopnea Index (AHI), the most widely accepted summary measure of sleep-disordered breathing severity for newborns who had fetal (prenatal) versus postnatal myelomeningocele repair. 35-42 weeks postmenstrual age
Secondary Association between neonatal sleep-disordered breathing and neurodevelopmental outcomes at 2 years of age for infants with myelomeningocele. Bayley-IV developmental exams will be performed on all subjects around 2-years of age. The Bayley-IV will determine if the subject's level of thinking, language, and motor skills are similar to the level of most children their age. Our assessment will be based off the Cognitive Subscale Score. It has a range from 40-160 with a mean score of 100 and standard deviation of 15. The scores will analyzed with regression models and general linear models to see if there is an association between Neonatal AHI for infants with myelomeningocele, fetal vs. postnatal myelomeningocele repairs, and neurodevelopmental outcomes. 22-26 months corrected age
Secondary Persistence of sleep-disordered breathing at 2-years of age Sleep studies will be performed at 2-years of age to capture AHI and compare to neonatal AHI for neonates who had fetal versus postnatal myelomeningocele repair. 22-26 months corrected age
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05547477 - Continuous EMG Measurements in Children With Asthma During Sleep
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00863421 - Sleep Disordered Breathing in Patients With Chronic Heart Failure N/A
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Not yet recruiting NCT05462834 - Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing N/A
Recruiting NCT01785199 - Effects of Head Elevation by a Bed on Sleep-disordered Breathing Phase 1
Recruiting NCT06043830 - Managing Opioid Related Sleep Apnea With Acetazolamide Phase 2
Recruiting NCT04351698 - SMILES: Study of Montelukast in Sickle Cell Disease Phase 2/Phase 3
Active, not recruiting NCT05643352 - Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring N/A
Recruiting NCT03142022 - Sleep-disordered Breathing After Solid Organ Transplantation
Recruiting NCT05336890 - Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Recruiting NCT05466864 - Screening of OSA in Hospitalized Stroke Patients Using BSP N/A
Recruiting NCT05661747 - Dental Appliance to Treat SDB in Children Phase 4
Completed NCT02855515 - Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea N/A
Recruiting NCT05575401 - Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy N/A
Completed NCT02923505 - Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)
Completed NCT06154577 - Tongue Morphology and Posterior Airway Space as Predictors of Response in Patientswith Hypoglossal Nerve Stimulation Therapy
Recruiting NCT04331821 - READ-ASV Registry - Phase II
Completed NCT02830074 - Treatment of Sleep-disordered Breathing in Patients With SCI N/A
Completed NCT02760680 - Validation of the Peripheral Arterial Tone to Detect Sleep-disordered Breathing in Patients With Chronic Heart Failure N/A

External Links